Upper GI 2017

Neoscope Study – What Can We Conclude?

 CarPacRT passed the pre-specified efficacy criteria for taking forward to phase III trial. OxCapRT failed to meet the same criteria

 CarPacRT can be taken forward to phase III.

© Universitätsmedizin Leipzig: University Cancer Center Leipzig (UCCL), Prof. Dr. F. Lordick